You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BCR-ABL Positive (BCR-ABL )

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +4 more
  • Eltrombopag Olamine
  • Houston, Texas
    M D Anderson Cancer Center
Jan 4, 2022

Real-World Usage of Asciminib Among Chronic Myeloid Leukemia in

Completed
  • Chronic Myeloid Leukemia
    • East Hanover, New Jersey
      Novartis
    Nov 20, 2023

    Chronic Myelogenous Leukemia - Chronic Phase Trial in Avignon (APN and medical management, Medical management, Quality of life

    Not yet recruiting
    • Chronic Myelogenous Leukemia - Chronic Phase
    • APN and medical management
    • +3 more
    • Avignon, Provence-Alpes-Côte d'Azur, France
      Centre Hospitalier d'Avignon, Hôpital Henri Duffaut
    Oct 13, 2023

    Chronic Lymphocytic Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Plasma Cell Myeloma Trial in Detroit (The DISCO

    Recruiting
    • Chronic Lymphocytic Leukemia
    • +2 more
    • The DISCO App
    • Usual Care
    • Detroit, Michigan
      Barbara Ann Karmanos Cancer Institute
    May 31, 2022

    Ex Vivo Drug Sensitivity Testing and Mutation Profiling

    Completed
    • Recurrent Childhood Acute Myeloid Leukemia
    • +13 more
      • Miami, Florida
        Nicklaus Children's Hospital
      Jan 18, 2023

      Information of Ponatinib, Bosutinib, Imatinib, Dasatinib and

      Completed
      • Leukemia
      • No Intervention
      • Cambridge, Massachusetts
        Takeda
      Feb 28, 2023

      Primary Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia Trial in Toronto (Observational)

      Recruiting
      • Primary Myelofibrosis
      • +9 more
      • Observational
      • Toronto, Ontario, Canada
        Princess Margaret Cancer Centre
      Apr 11, 2022

      Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia Trial in

      Suspended
      • Juvenile Myelomonocytic Leukemia
      • +27 more
      • CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
      • +2 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Jan 11, 2023

      Chronic Myeloid Leukemia Any Phase Treated With Ponatinib at Any

      Active, not recruiting
      • Chronic Myeloid Leukemia, Chronic Phase
        • Jena, Germany
          University Hospital Jena
        Jan 17, 2023

        Leukemia, Myelogenous, Chronic Trial in Changchun (CTTQ Dasatinib tablet, Sprycel Dasatinib tablet)

        Completed
        • Leukemia, Myelogenous, Chronic
        • CTTQ Dasatinib tablet
        • Sprycel Dasatinib tablet
        • Changchun, Jilin, China
          Affiliated Hospital of Changchun University of Traditional Chine
        Dec 7, 2022

        CML, Chronic Phase, CML, Accelerated Phase Trial in Wuhan (HS-10382(Part 1: Dose escalation), HS-10382(Part 2: Dose expansion))

        Recruiting
        • CML, Chronic Phase
        • CML, Accelerated Phase
        • HS-10382(Part 1: Dose escalation)
        • HS-10382(Part 2: Dose expansion)
        • Wuhan, Hubei, China
          Union Hospital affiliated to Tongji Medical College of Huazhong
        Jan 12, 2023

        Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling

        Recruiting
        • Recurrent Childhood Acute Myeloid Leukemia
        • +17 more
          • Miami, Florida
            Nicklaus Children's Hospital
          May 13, 2023

          Chronic Myelogenous Leukemia Trial in Houston (TGRX-678)

          Not yet recruiting
          • Chronic Myelogenous Leukemia
          • Houston, Texas
            The University of Texas MD Anderson Cancer Center
          Oct 12, 2023

          Tyrosine Kinase Inhibitors, Chronic Myeloid Leukemia Trial in Poitiers (treatment of TKI in CML)

          Not yet recruiting
          • Tyrosine Kinase Inhibitors
          • Chronic Myeloid Leukemia
          • treatment of TKI in CML
          • Poitiers, France
            Chu Poitiers
          Feb 21, 2023

          Chronic Myeloid Leukemia Trial (Asciminib)

          Available
          • Chronic Myeloid Leukemia
          • (no location specified)
          Jan 17, 2023

          CML Trial in Ciudad Autonoma de Buenos Aire (Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment)

          Recruiting
          • CML
          • Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment
          • Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina
            FUNDALEU
          Jun 29, 2023

          Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia

          Completed
          • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
          • +14 more
          • Aldesleukin
          • +7 more
          • Houston, Texas
            M D Anderson Cancer Center
          Jul 31, 2022

          Ponatinib in CML Patients in Chronic Phase

          Recruiting
          • Chronic Myeloid Leukemia, Chronic Phase
          • Therapeutic drug monitoring
          • Molecular Response
          • Cagliari, Italy
          • +4 more
          Nov 3, 2023

          Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Trial (Asciminib, Nilotinib)

          Not yet recruiting
          • Philadelphia Chromosome-Positive Chronic Myeloid Leukemia
          • (no location specified)
          Jul 11, 2022

          Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic Myelogenous Leukemia Trial in Philadelphia (Text

          Recruiting
          • Chronic Myelogenous Leukemia, BCR-ABL1 Positive
          • Chronic Phase Chronic Myelogenous Leukemia
          • Text Message-Based Navigation Intervention
          • Survey Administration
          • Philadelphia, Pennsylvania
            Sidney Kimmel Cancer Center at Thomas Jefferson University
          Apr 7, 2022

          Recurrent Acute Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent Blastic Plasmacytoid Dendritic Cell Tumor Trial in

          Recruiting
          • Recurrent Acute Leukemia
          • +16 more
          • Duarte, California
            City of Hope Medical Center
          Nov 22, 2022

          Chronic Myelogenous Leukemia, Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia Trial in Worldwide (ABL001, ABL001 +

          Active, not recruiting
          • Chronic Myelogenous Leukemia
          • Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
          • Boston, Massachusetts
          • +18 more
          Jan 19, 2023

          TyrosIne Kinase Inhibitors in Chronic Myeloid Leukemia: Efficacy

          Recruiting
          • Chronic Myeloid Leukemia
          • Pisa, Italy
          • +1 more
          Jan 4, 2022

          Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Atypical Chronic Myeloid

          Active, not recruiting
          • Acute Myeloid Leukemia
          • +9 more
          • Los Angeles, California
          • +5 more
          Jan 27, 2023

          Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia

          Active, not recruiting
          • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
          • +36 more
          • Buffalo, New York
            Roswell Park Cancer Institute
          Jan 23, 2023